(Q46521675)

English

Tubulointerstitial nephritis and IgA nephropathy in a patient with advanced lung cancer treated with long-term gefitinib

scientific article published on 25 June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

Tubulointerstitial nephritis and IgA nephropathy in a patient with advanced lung cancer treated with long-term gefitinib (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

author name string

Kohsuke Masutani

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

Kiichiro Fujisaki

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

Hiroto Maeda

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

Jiro Toyonaga

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

Ichiro Inoshima

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

Koichi Takayama

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

Ritsuko Katafuchi

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

Hideki Hirakata

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

Kazuhiko Tsuruya

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

Mitsuo Iida

10

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

publication date

25 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

Clinical and experimental nephrology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

12

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

398-402

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

https://scigraph.springernature.com/pub.10.1007/s10157-008-0066-1

0 references

Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18575950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18575950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myocarditis temporally related to the use of gefitinib (Iressa).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18575950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-infectious acute glomerulonephritis with predominant mesangial deposition of IgA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18575950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor tyrosine kinase inhibition augments a murine model of pulmonary fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18575950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe acute interstitial pneumonia and gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/18575950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18575950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal tubular cells are potential targets for epidermal growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/18575950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Side effects of therapy: case 1. Nephrotic syndrome associated with gefitinib therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18575950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel mechanisms of tubulointerstitial injury in IgA nephropathy: a new therapeutic paradigm in the prevention of progressive renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18575950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/18575950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation recall pneumonitis induced by Gefitinib (Iressa): a case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/18575950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/18575950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18575950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10157-008-0066-1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18575950

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46521675&oldid=2115813516"